Three GEO datasets were identified when the 1KB domain of the SNAI2 TSS was investigated for potential VDR binding in lymphocytes, hepatocytes, and prostate cancer cells (Figure 6F). This evidence concerns the gene SNAI2 and prostate carcinoma.